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Bone pain is the most common type of pain in cancer. Bony metastases are common in advanced cancers, particularly in
multiple myeloma, breast, prostate or lung cancer. Current pain-relieving strategies include the use of opioid-based analgesia,
bisphosphonates and radiotherapy. Although patients experience some pain relief, these interventions may produce unacceptable
side-eﬀects which inevitably aﬀect the quality of life. Acupuncturemay represent a potentially valuable adjunct to existing strategies
for pain relief and it is known to be relatively free of harmful side-eﬀects. Although acupuncture is used in palliative care settings
for all types of cancer pain the evidence-base is sparse and inconclusive and there is very little evidence to show its eﬀectiveness
in relieving cancer-induced bone pain (CIBP). The aim of this critical review is to consider the known physiological eﬀects of
acupuncture and discuss these in the context of the pathophysiology of malignant bone pain. The aim of future research should be
to produce an eﬀective protocol for treating CIBP with acupuncture based on a sound, evidence-based rationale. The physiological
mechanisms presented in this review suggest that this is a realistic objective.
1. Introduction
Bone pain is the most common type of pain in cancer. Bony
metastases are common in advanced cancers, particularly
in multiple myeloma, breast, prostate or lung cancer and
they occur more commonly on the axial skeleton [1, 2].
Nowadays, the survival rate of many patients after diagnosis
of bone metastases is relatively long, particularly in breast
and prostate cancers where survival may be measured in
years [1, 3]. Therefore it is important to control pain and
preserve function to enable these patients to enjoy as high
a quality of life as possible [4].
Current pain-relieving strategies include the use of
opioid-based analgesia, bisphosphonates and radiotherapy.
Although patients experience some pain relief, these inter-
ventions may produce unacceptable side-eﬀects. In particu-
lar, the use of opioid-based analgesia commonly results in
side-eﬀects including constipation, nausea and drowsiness.
A common symptom experienced by patients with cancer-
induced bone pain (CIBP) is spontaneous breakthrough
pain, which is severe and diﬃcult to control because the
levels of medication required for pain relief would be
unacceptable [2, 5].
Acupuncture may represent a potentially valuable
adjunct to existing strategies for pain relief and is known
to be relatively free of harmful side-eﬀects [6–8]; however,
although acupuncture is widely used in palliative care
settings [9] for all types of cancer pain the evidence-base is
sparse and inconclusive [10]. Furthermore, safety guidelines
for the use of acupuncture treatment in cancer patients exist
[11], yet there have been no studies specifically looking at
adverse events in patients with bony metastases and no high-
quality randomized controlled trials have been conducted to
investigate the eﬀects of acupuncture on CIBP. Acupuncture
is available widely in the palliative care setting [9] but the
evidence-base is poor. The most recent systematic review of
acupuncture for cancer pain was inconclusive and did not
specifically mention CIBP [12]. We are in the process of
undertaking a Cochrane Systematic Review of acupuncture
for cancer pain, and our literature search, which has incor-
porated detailed search strategies of seven major databases
and includes searches of integrative and complementary
medicine journals, has found no randomized controlled
trials specifically evaluating acupuncture as a treatment
for CIBP [13]. Furthermore, our review of literature has
not revealed any other types of studies in humans either
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investigating the eﬀects of acupuncture on CIBP or providing
a comprehensive scientific debate on its potential as a
treatment for this type of pain. However, recent animal
studies have investigated the eﬀects of electroacupuncture
on rat models of CIBP and these give us an insight into
the mechanisms involved in mediating acupuncture-induced
analgesia [14–16]. The aim of this critical review is to
consider the known physiological eﬀects of acupuncture
and discuss these in the context of the pathophysiology of
malignant bone pain.
2. Physiological Rationale for
Using Acupuncture to Reduce CIBP
2.1. The Mechanisms Underlying CIBP. The physiological
mechanisms of bone pain are not fully understood [17], but
the pathophysiology of bony metastases suggests that the
following factors are likely to be causative [5]:
(i) The release of chemical mediators, such as cytokines,
from tumor cells.
(ii) Increased pressure within the bone.
(iii) Microfractures.
(iv) Periosteal stretching.
(v) Muscle spasm.
(vi) Nerve root infiltration.
(vii) Nerve compression (due to vertebral collapse).
It is likely that a combination of peripheral and central
mechanisms contributes to pain associated with bony
metastases and these are described below and illustrated in
Figure 1.
2.1.1. Peripheral Mechanisms. periosteum is well innervated
and the sensory free nerve endings present are thought
to be involved in the mediation of pain. Although the
precise mechanisms are unclear, it is thought that excessive
osteoclast-induced bone destruction leads to pain through
stimulation of mechanoreceptors in the periosteum [18].
Sensory nerve fibers may also be destroyed due to excessive
osteoclastic activity and this may lead to neuropathic-type
pain [18]. Sensory neurons in the periosteum are also
aﬀected by increased mechanical stress within the bone
which may lead to pain and increased sensitization [19].
This eﬀect is enhanced by the presence of inflammatory
cells within the tumor caused by an osteoblastic response,
contributing to a local acidosis and in turn sensitizing acid-
sensing ion channels such as the transient receptor potential
vanilloid receptor 1 (TRPV1). Studies have shown that
TRVP1 is important in the integrative signaling in CIBP
and inhibiting its release is important in controlling complex
pain states [20]. Tumor cells and tumor stromal cells secrete
various inflammatory cells that contribute to the sensiti-
zation of excitation of primary aﬀerent neurons, causing
peripheral sensitization. One product that is significant in
CIBP is nerve growth factor (NGF), which also acts to
intensify nociceptive transmission in the dorsal horn [21].
2.1.2. Central Mechanisms. It has been suggested that CIBP
is a unique pain state showing physiological characteristics
of both inflammatory and neuropathic pain and changes in
dorsal horn cell phenotype [21–24]. Whereas inflammatory
pain states are characterized by up-regulation of calcitonin
gene-related peptide (CGRP), and neuropathic pain states
by up-regulation of neuropeptide Y (NPY), CIBP is distinct
in that there is an up-regulation of dynorphin in the deep
dorsal horn and increased expression of c-fos [23, 25]. In
addition, it has been shown in rat models of CIBP that
repetitive noxious stimulation of primary C-fiber aﬀerents
results in a “wind-up” phenomenon which is characterized
by an escalation of nociceptive transmission by cells in
the dorsal horn [23, 24]. Wind-up contributes to central
sensitization via wide-dynamic range (WDR) cells resulting
in the amplification and prolongation of nociceptive trans-
mission in ascending pathways in the central nervous system.
This sensitizing eﬀect results in sensitivity to normally non-
noxious mechanical and thermal stimuli (allodynia) and
exaggerated responses to noxious stimuli (hyperalgesia).
Central sensitization is mediated via activation of the N-
methyl-d-aspartate (NMDA) glutamate receptor and is a
feature of many chronic pain states.
Studies using rat models of CIBP have also shown that
the proportion of WDR neurons almost doubles in the
presence of bony metastases. The proportion of nociceptive-
specific (NS) to WDR neurons in normal controls is 74 :
26%, and changes to 53 : 47%, respectively, during CIBP
[23]. This means that neurons which normally respond to
noxious stimuli start to respond to non-noxious stimuli
resulting in allodynia and hyperalgesia [23, 26]. Thus, central
sensitization and changes in phenotype of dorsal horn
neurons will result in hypersensitivity to mechanical input
and be responsible for movement-related pain which is
characteristic of CIBP.
It has been shown that CIBP causes a decrease in μ-
opioid receptors in dorsal root ganglia and this may explain
the decreased response to opiate drugs such as morphine.
This response was not shown in inflammatorymodels, where
morphine was eﬀective in reducing pain [17]. CIBP-induced
changes in the endogenous opioid system may also aﬀect
structures on the descending pain inhibitory pathways which
are involved in regulating spinal responses to pain via sensory
input [27], for example, the periaqueductal gray (PAG) and
parabrachial areas of the brain that release dynorphin and
in turn activate the serotogenic system within the brainstem
and spinal cord.
The multifactorial mechanisms underlying CIBP prob-
ably explain why the level of pain experienced by patients
does not necessarily correspond with the extent of the bony
metastases [18, 19]. Coupled with aﬀective and cognitive
factors associated with the prognosis of CIBP, this presents a
complex pain state requiring a multidisciplinary approach to
pain management and a unique problem when considering
appropriate mechanisms of analgesia.
2.2. How Can Acupuncture Influence the Physiology of CIBP?
Many of the studies investigating the physiological eﬀects
of acupuncture have been conducted in the laboratory and
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Figure 1: Mechanisms of cancer-induced bone pain.
a significant number have used animal subjects [14–16,
28–30]. Because so little clinical evidence exists we have
had to rely on these laboratory studies for our discussion,
yet they have shortcomings in relation to clinical practice
because many “human” factors play a part in the therapeutic
process and the ideal conditions of the laboratory cannot
be reproduced in the clinic. However, these studies provide
us with useful guidance on which mechanisms may act to
produce the desired therapeutic eﬀect, and the clinician must
use skill and judgment to adapt these guidelines according to
the individual patient. Acupuncture is likely to be eﬀective
in treating CIBP if it can reduce pain transmission and/or
sensitization at peripheral and central sites (Figure 2).
2.2.1. Segmental Analgesia and Desensitization. Acupuncture
stimulates small myelinated Aδ fibers in muscle and skin
which synapse with interneurones in the substantia gelati-
nosa (SG) of the spinal cord resulting in the release of
inhibitory neuromodulators such as enkephalin that reduce
activity in NS and WDR neurons [31]. It is claimed that it
is necessary to retain the needles in situ for 10–20min to
ensure the release of enkephalin [32]. Reduced nociceptive
transmission in the dorsal horn following Aδ input (long-
term depression) has been shown to outlast the stimulation
by hours [33, 34].
Continuous or repetitious stimulation of Aδ fibers using
electrical currents has been shown to reduce sensitization of
postsynaptic receptors and/or a decrease in neurotransmitter
release in the dorsal horn in normal rats [34]. Other studies
have used rat models of CIBP to investigate the eﬀects of
electroacupuncture on cancer-induced hyperalgesia [14, 15].
Daily treatment for 30min at 10Hz/2mA/0.4ms pulse for
5 days suppressed expression of dynorphin in the dorsal
horn of rats with artificially induced bone cancer [15].
Dynorphin is known to facilitate hyperalgesia and it was
suggested that suppression of this may inhibit CIBP, as
was demonstrated in the rat model. In a similar study,
interleukin-1β expression was measured in rats with CIBP-
related hyperalgesia, as this is related to the maintenance
of persistent pain [14]. The data suggested that because
electroacupuncture suppressed interleukin-1β expression it
would therefore be an eﬀective treatment for the treatment of
CIBP. Another recent animal study used a neuropathic cancer
pain model in mice and found that electroacupuncture
decreased levels of substance P in the dorsal horn but
increased levels of β-endorphin in the blood by 51.5% and
in the brain by 12.6%, suggesting that it may be useful as
an alternative treatment for this type of cancer-related pain
[16]. In all the animal studies, however, it must be borne
in mind that the doses of electroacupuncture applied in the
laboratory represent “ideal” conditions which might not be
possible to attain in the clinic, and the findings of these
studies have yet to be applied to human subjects.
Further animal studies have shown that acupuncture
[33–35], electroacupuncture [33–35] and transcutaneous
electrical nerve stimulation (TENS) [34, 36] reduce central
sensitization and may therefore be useful in CIBP [37]. Reg-
ular treatment at a low-frequency which maintains analgesia
and produces a long-term depression in the dorsal horn may
be achieved by stimulation of aﬀerent Aδ fibers using manual
acupuncture alone and studies using rats have shown that
this depression may last for days or weeks [33, 35]. Recent
studies using mice have shown that manual acupuncture
with bidirectional stimulation stimulates connective tissue
which generates a strong aﬀerent input to the dorsal horn
and is therefore likely produce a depressing eﬀect [28, 38].
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Figure 2: Mechanisms of acupuncture analgesia.
However, these connective tissue responses have yet to be
reproduced in the human population to determine whether
they are related to therapeutic eﬀects. It has also been
suggested that the release of oxytocin in response to non-
noxious sensory stimulation such as manual acupuncture
may give rise to long-term elevations in pain threshold [35].
It is therefore likely that acupuncture should help to prevent
wind-up, central sensitization and the resultant allodynia
and hyperalgesia.
The need for regular and repetitive stimulation of aﬀerent
Aδ fibers to achieve long-lasting analgesia is borne out by
anecdotal evidence, which suggests that patients with cancer
pain need to be treated two or three times per week initially
for optimal eﬀects, particularly in cases of CIBP where pain
relief is often achieved for a very short time [39]. For treating
CIBP, consideration should be given to the segmental
innervations (sclerotomes) of bones aﬀected by metastatic
deposits. Application of acupuncture needles to the muscles
corresponding with the same spinal segment (myotomes)
should result in analgesia throughout the segment. Also, as
each aﬀerent nerve originates from more than one spinal
segment, the application of needles from adjacent segments
will increase the eﬀect of the stimulation.
2.2.2. Extrasegmental Eﬀects. The cumulative response of
acupuncture may also be demonstrated by permanent
changes in the opioid peptide mechanism which enhances
gene expression. The arcuate nucleus of the hypothalamus
is activated by peripheral Aδ fiber input resulting from
acupuncture and β-endorphin is released, which has an eﬀect
on the PAG via the descending pain inhibitory system. This
is similar to the eﬀect of opioid drugs in stimulating the
release of serotonin and met-enkephalin that inhibit the
SG cells, and is supported by clinical trials which showed
that naxolone reverses some of the pain-relieving eﬀects of
acupuncture and electroacupuncture [30, 40–42].
The relatively sustained eﬀects of acupuncture analgesia
might be due to an up-regulation in analgesic gene expres-
sion, which demonstrates the importance of regular “top-
ups”. It has also been suggested that sustained analgesia may
bemaintained by a positive feedback loop in themeso-limbic
system which results in a continuous outflow from descend-
ing inhibitory pathways [31, 43]. Cumulative stimulation of
Aδ fibers also results in increased amounts of peptides being
manufactured and stored, therefore prolonging the analgesic
response to acupuncture. Furthermore, up-regulation of the
opioid peptide mechanism as a cumulative result of Aδ
stimulation has been found to activate μ-opioid receptors
and increase their binding potential, thus overriding central
changes to the endogenous opioid system in CIBP [44].
Non-opioid systems also play an important part in
acupuncture analgesia. The release of serotonin in the brain-
stem activates descending inhibitory systems resulting in the
release of more serotonin and noradrenaline in the dorsal
horn. Noradrenalinemodulates pain transmission within the
dorsal horn by inhibiting the post-synaptic membrane of
SG cells, thus reinforcing the eﬀects of the opioid-peptide
mechanism [45].
An immediate and powerful sympathetic response occurs
within a segmental distribution when needles are inserted. In
the long-term, in addition to depressing pain transmission
within the dorsal horn it reduces pain perception and
produces an autonomic blockade by interrupting autonomic
reflexes [32]. This is a cumulative eﬀect occurring over sev-
eral treatments. Acupuncture also aﬀects autonomic activity
in the hypothalamus and this might explain why patients
Evidence-Based Complementary and Alternative Medicine 5
feel relaxed and occasionally drowsy after treatment. The use
of auricular (ear) acupuncture to elicit autonomic eﬀects
may also be useful for pain relief in CIBP but the precise
mechanisms of this type of acupuncture remain unclear [36].
It is based on the assumption that all internal organs are
represented on the ear, but unfortunately so many diﬀerent
maps exist that there is little agreement as to point location
[46, 47]. There is some evidence that auricular acupuncture
is useful for postoperative pain [47], cancer pain [48] and for
vasomotor symptoms associated with hormone therapy in
cancer patients [49], but not CIBP and therefore this would
be an interesting area for further research.
2.2.3. Central Eﬀects. Functional brain imaging studies have
demonstrated that the application of acupuncture aﬀects
the limbic system, which modulates emotional (aﬀective)
responses to pain [50–54]. The way acupuncture aﬀects the
emotional component of CIBP has emerged as a result of
brain imaging studies, which show that sensory input may be
modulated by the emotional reaction and cognitive aspects
of pain and vice versa [55–57]. This is borne out by recent
studies investigating the mechanisms of placebo analgesia
[58–60].
The eﬀect of acupuncture on the limbic system might
also explain why some patients (strong reactors) experience
a euphoric reaction to acupuncture. The phenotypic changes
in lamina I neurons in the dorsal horn mentioned earlier
are also likely to contribute to the aﬀective and autonomic
responses associated with CIBP [23]. The central modulation
of pain is important in CIBP because it reduces the unpleas-
antness of pain and aﬀects how well patients tolerate it. One
of the key features of this is the C fiber tactile system where
light stimulation of the skin stimulates mechanoreceptors
and induces a response in the limbic system. This reduces the
aﬀective component of pain and increases the sense of well-
being [61], and for this reason it may be that point specificity
is not as important for central pain modulation as it is in
segmental acupuncture [62].
2.2.4. Myofascial Trigger Points. Another manifestation of
chronic pain is the presence of reactive muscle spasm
which in turn causes additional pain and shortening of the
muscle, aﬀecting function [63]. The use of acupuncture for
myofascial trigger points (MTPs) may be a useful way of both
alleviating discomfort and improving functional status. A
recent study using anesthetic injected into MTPs in chronic
neck pain has confirmed that function can be improved by
eradicating these points [64]. It was suggested that MTPs
serve to perpetuate lowered pain thresholds in uninjured tis-
sues and that central sensitization may itself be perpetuated
by the presence of MTPs [64]. Where MTPs are present as a
result of CIBP they are likely to perpetuate themselves by the
continual release of acetylcholine (ACh) causing a sustained
contraction, which increases energy demands in the muscle
but impedes the circulation. Nociceptive neurotransmitters
are released and it is thought that this has a sensitizing eﬀect
on the muscle endplates which in turn contribute to the
continued release of ACh in a feedback loop [32]. The use
of acupuncture to normalize muscle tone may break this
feedback loop and reduce perpetual central sensitization.
The eﬀect of acupuncture on MTPs in normalizing
muscle tone, restoring muscle balance and thus improving
mobility and function has been noted in cancer patients and
is therefore an important outcome for patients suﬀering from
CIBP [65].
2.3. The Clinical Use of Acupuncture in CIBP
2.3.1. Prevalence of Acupuncture for CIBP. There is evidence
to suggest that acupuncture is widely used in palliative
cancer care [9, 39, 66, 67], and large surveys show that
a relatively high percentage of cancer patients use various
complementary therapies for pain and other symptoms [68–
70]. Clinical experience suggests that acupuncture is eﬀective
for treating CIBP, although there is no published information
indicating the extent of its use in practice.
2.3.2. Safety of Acupuncture in CIBP. Although studies
have shown acupuncture to be relatively safe from serious
adverse eﬀects [7, 8] the unique characteristics of CIBP
require careful consideration. The presence of hyperalgesia
or allodynia as a result of CIBP presents potential problems
for the acupuncturist in that patients might not tolerate
the treatment. Any short-term exacerbation of pain as a
result of acupuncture may not be tolerable for patients who
are already overburdened with severe pain and therefore
caution is required with patients who are likely to be strong
reactors [32, 71]. It is suggested that strong reactors are often
individuals who are more influenced by sensory stimulation
and may be artistic or inclined toward religious belief,
although there is little published evidence of this [72, 73]. As
with all new treatments, acupuncture should be introduced
cautiously at first so the reactions of the patient may be mon-
itored. It must be said, however, that strong reactors are often
good responders, even with minimal stimulation, and there-
fore it might only be necessary to insert the needles for a very
short time to achieve the desired amount of stimulation [74].
Patients undergoing cancer treatment such as chemo-
therapy can become severely immunosuppressed and
potentially more vulnerable to infection and bleeding due
to low platelet counts. This represents a known risk but is
regarded as an unlikely occurrence provided safety guidelines
are followed and practitioners liaise closely with oncology
staﬀ and maintain a close scrutiny of blood counts [11, 71].
The insertion of needles causes tissue damage and the
resulting inflammation increases local blood flow which
is normally a desired eﬀect because it promotes tissue
healing. However, in cancer an increase in blood flow might
not be desirable, particularly around the site of a tumor
because it could encourage proliferation or metastatic spread
(although we have found no evidence for this). Caution
must also be used when lymphedema is present due to a
risk of infection and cellulitis [71] and it is recommended
that the contralateral limb is needled in these cases [11].
If acupuncture is eﬀective in alleviating pain, one might
assume that it could mask tumor progression. However,
based on clinical experience it has been suggested that where
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patients who have been previously responsive to acupuncture
suddenly stop responding, this might be a sign that there is
metastatic spread and they should therefore be checked for
disease progression [11, 32, 71, 75].
The eﬀect of acupuncture on MTPs and muscle spasm
must be borne in mind when needling around the spine.
Muscle spasm may be acting to protect spinal instability
due to metastatic growth and the reduction of this spasm
by acupuncture may result in spinal collapse and cord
transaction, though we have found no published evidence
of this [11, 71]. Although evidence suggests that the direct
risk of adverse events due to acupuncture in patients with
CIBP is relatively low, practitioners must keep in mind the
“indirect” risk that patients may regard acupuncture as a true
alternative to conventional treatments and suﬀer unduly as a
result [70].
2.3.3. Clinical Eﬃcacy and Eﬀectiveness. The extent of the use
of acupuncture in CIBP is not known although anecdotal
evidence and preliminary clinical data are available. In a
small, uncontrolled trial (n = 28) of four groups of palliative
care patients, including patients with neuropathic pain,
benign soft tissue pain, benign bone pain and malignant
bone pain, significant pain relief was achieved in all groups
using auricular stud acupuncture [67]. Clinical data collected
from a UK hospice over 12 months showed that 10 out of
15 patients with bone pain experienced either “excellent”
or “good” pain relief following treatment with acupuncture,
although no details of treatment protocols were given [66].
Filshie [39] collected clinical data over a period of 5 years
involving 156 patients who attended cancer clinics and were
treated with acupuncture. The results of the treatment were
promising, although it was stated that acupuncture is only
useful in “selected patients” with bone pain. No further
details were given on which patients with bone pain might
benefit from acupuncture.
The most recent systematic review on acupuncture
for cancer-related pain was inconclusive and none of the
included studies used CIBP populations [12]. Recently, we
have published a protocol for undertaking a Cochrane review
on acupuncture for cancer pain in adults with particular
emphasis on CIBP [13]. Our literature searches have revealed
no high-quality evidence for the eﬃcacy of acupuncture in
treating CIBP in humans.
3. Summary: Future Research
CIBP is a unique pain state and is characterized by central
sensitization and an “up-regulated” nociceptive system.
Acupuncture is known to reduce central sensitization in
the dorsal horn and to reduce transmission of nociceptive
information. It is likely that regular treatments reduce
ongoing nociceptive transmission and sensitization and up-
regulate the opioid peptide system. The release of MTPs
may also help to lower central sensation. Additionally, the
eﬀect of acupuncture on the limbic system in the brain may
modulate emotional responses to pain and render it more
tolerable. Future research must focus upon well-designed
randomized controlled clinical trials using human subjects
to specifically investigate the eﬀect of acupuncture on CIBP
and focus in particular upon aspects of needle placement and
dosage for optimal results. The aim of such research should
be to produce an eﬀective protocol for treating CIBP based
on a sound, evidence-based rationale. The physiological
mechanisms presented here suggest that this is a realistic
objective.
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